in men with RMD treated with CYC. CYC may cause infertility and long-term gonadal damage in treated men. Options for fertility preservation should be presented to male patients in whom CYC therapy is required. We conditionally recommend against testosterone co-therapy in men with RMD receiving CYC, as it does not preserve fertility in men undergoing chemotherapy for malignancy Because sperm cryopreservation prior to treatment preserves a man's ability to conceive a healthy child, we strongly